Butanolides from Machilus thunbergii and their inhibitory activity on nitric oxide synthesis in activated macrophages

Phytotherapy Research

Volumn 17, Issue 4, 2003, Pages 372-375

  Kim, Nam Yi ^a   Ryu, Jae Ha ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Butanolide; Inhibitor; Lipopolysaccharide; Machilus thunbergii; Nitric oxide synthase

Indexed keywords

ANTIINFLAMMATORY AGENT; BUTYROLACTONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; LITSENOLIDE A2; LITSENOLIDE B1; LITSENOLIDE B2; MACHILUS THUNBERGII EXTRACT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ISOLATION; ENDOTOXEMIA; ENZYME ACTIVITY; MACHILUS THUNBERGII; MACROPHAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; SEPTIC SHOCK;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; HUMANS; LAURACEAE; LIPOPOLYSACCHARIDES; MACROPHAGES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; SHOCK, SEPTIC;

MACHILUS; PERSEA THUNBERGII;

EID: 0037545845     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1160     Document Type: Article

References (26)

1. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
2. Bredt DS, Snyder SH. 1990. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685.
3. Chen IS, Lai-Yaun IL, Duh CY, Tsai IL. 1998. Cytotoxic butanolides from Litsea akoensis. Phytochemistry 49: 745-750.
4. Choi YE, Ahn A, Ryu JH. 2000. Polyacetylenes from Angelica gigas and their inhibitory activity on the nitric oxide synthesis in activated macrophages. Biol Pharm Bull 23: 884-886.
5. Dirsch VM, Stuppner H, Ellmerer-Muller EP, Vollmar AM. 2000. Structural requirements of sesquiterpene lactones to inhibit LPS-induced nitric oxide synthesis in RAW 264.7 macrophages. Bioorg Med Chem 8: 2747-2753.
6. Forstermann U, Schmidt HHHW, Pollock JS, et al. 1991. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42: 1849-1857.
7. 13N]nitrate in biological fluids. Anal Biochem 126: 131-138.
8. Jung JP, Bae KH. 1996. Antibacterial compositions comprising magnolol and honokiol from Machili cortex. Korean patent No. KR 9607923.
9. Kilbourn RG, Belloni P. 1990. Endothelial cell production of nitrogen oxides in response to interferon in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 82: 772-776.
10. Kim EJ, Jin HK, Kim YK, et al. 2001. Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activation. Biochem Pharmacol 61: 903-910.
11. Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP. 1999. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 58: 759-765.
12. Kwon BM, Jung HJ, Lim JH, et al. 1999. Acetyl-CoA:cholesterol acetyltransferase inhibitory activity of lignans isolated from Schizandra, Machilus, and Magnolia species. Planta Med 65: 74-76.
13. Kwon HC, Baek NI, Choi SU, Lee KR. 2000. New cytotoxic butanolides from Lindera obtusiloba Blume. Chem Pharm Bull 48: 614-616.
14. Lee HJ, Kim NY, Jang MK, et al. 1999. A Sesquiterpene, dehydrocostus lactone, inhibits the expression of inducible nitric oxide synthase and TNF-α in LPS-activated macrophages. Planta Med 65: 104-108.
15. Liu L, Riese J, Resch K, Kaever V. 1994. Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum. Arzneimittelforschung 44: 1223-1226.
16. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 89: 6711-6715.
17. Matsuda H, Kageura T, Oda M, Morikawa T, Sakamoto Y, Yoshikawa M. 2001. Effects of constituents from the bark of Magnolia obovata on nitric oxide production in lipopolysaccharide-activated macrophages. Chem Pharm Bull 49: 716-720.
18. Matsuda H, Murakami T, Kageura T, et al. 1998. Hepatoprotective and nitric oxide production inhibitory activities of coumarin and polyacetylene constituents from the roots of Angelica furcijuga. Bioorg Med Chem Lett 8: 2191-2196.
19. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63.
20. Oshima H, Bartsch H. 1994. Chronic infectious and inflammation process as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305: 253-264.
21. Ryu JH, Jeong YS, Sohn DH. 1999. New bisabolene epoxide from Tussilago farfara and the inhibition of nitric oxide synthesis in LPS-activated macrophages. J Nat Prod 62: 1437-1438.
22. Ryu JH, Lee HJ, Jeong YS, Ryu SY, Han YN. 1998. Yomogin, an inhibitor of nitric oxide production in LPS-activated macrophages. Arch Pharm Res 21: 481-484.
23. Stuehr DJ, Cho HJ, Kwon NS, Weise M, Nathan CF. 1991. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88: 7773-7777.
24. Takeda K, Sakurawi K, Ishii H. 1972. Components of the Lauracea family, I. New lactonic compounds from Litsea japonica. Tetrahedron 28: 3757-3766.
25. Thiemermann C, Vane J. 1990. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182: 591-595.
26. 4-injured primary cultures of rat hepatocytes. J Pharm Pharmacol 52: 1163-1169.